You just read:

NOVEN ANNOUNCES POSITIVE PHASE 3 DATA RESULTS FOR INVESTIGATIONAL LOW-DOSE NONHORMONAL THERAPY FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE

News provided by

Noven Pharmaceuticals, Inc.

Oct 03, 2012, 12:01 ET